Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Human embryonic stem cells: a potential source for cellular therapy.

Sharon Gerecht-Nir¹, Joseph Itskovitz-Eldor

¹Biotechnology Interdisciplinary Unit, Technion - Israel Institute of Technology, Haifa, Israel.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons

|February 12, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Selection for CD26<sup>-</sup> and CD49A<sup>+</sup> Cells From Pluripotent Stem Cells-Derived Islet-Like Clusters Improves Therapeutic Activity in Diabetic Mice.

Frontiers in endocrinology·2021

Same author

Derivation of Pericytes from Human Pluripotent Stem Cells.

Methods in molecular biology (Clifton, N.J.)·2021

Same author

Cardiac Fibroblast-Induced Pluripotent Stem Cell-Derived Exosomes as a Potential Therapeutic Mean for Heart Failure.

International journal of molecular sciences·2020

Same author

Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1<sup>G93A</sup> and NSG animal models.

Stem cell research & therapy·2018

Same author

20th Anniversary of Isolation of Human Embryonic Stem Cells: A Personal Perspective.

Stem cell reports·2018

Same author

Scalable Expansion of Pluripotent Stem Cells.

Advances in biochemical engineering/biotechnology·2017

Same journal

Alpha-Gal Syndrome: Unrecognized Risks of a Tick-Bite-Associated Allergy in Transplantation and Cellular Therapy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Same journal

Comment on "Role of social determinants and outcomes of patients with alcohol-associated liver disease referred for early liver transplantation: A multicenter analysis".

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Same journal

Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Same journal

Donor Acute Kidney Injury Is Not Associated With Inferior Outcomes After Simultaneous Pancreas-Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Same journal

Human Biopsy-Defined IRI-Selective Reperfusion Signature Prioritizes Reperfusion-Timed MEK Inhibition After DCD Liver Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Same journal

OPERATIONAL TOLERANCE FOLLOWING INTESTINAL TRANSPLANTATION: A CASE REPORT WITH COMPREHENSIVE IMMUNE FOLLOW-UP FROM TRANSPLANT DAY TO THREE YEARS POST-IMMUNOSUPPRESSION WITHDRAWAL.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

See all related articles

Human embryonic stem (hES) cells offer potential for treating degenerative diseases through cell transplantation. This review explores hES cell applications in cardiovascular repair and related ethical considerations.

Area of Science:

Regenerative Medicine
Stem Cell Biology
Cardiovascular Research

Background:

Degenerative diseases like diabetes and Parkinson's involve irreparable cell damage.
Cellular therapy using transplanted healthy cells shows promise for treating these conditions.
Human embryonic stem (hES) cells can differentiate into various cell types, making them a potential source for regenerative therapies.

Purpose of the Study:

To review the derivation, maintenance, and safety of human embryonic stem (hES) cells for cellular therapy.
To discuss the ethical considerations associated with using hES cells.
To emphasize the application of hES cells in cardiovascular repair, including the generation and characterization of derived cardiomyocytes and vascular progenitors.

Main Methods:

Related Experiment Videos

Review of existing literature on hES cell derivation and maintenance.

Analysis of studies on hES cell differentiation into cardiovascular lineages.

Examination of safety protocols and ethical guidelines for hES cell use.

Main Results:

hES cells can be derived and maintained in vitro for potential therapeutic use.
Successful differentiation of hES cells into cardiomyocytes and vascular progenitors has been demonstrated.
Established protocols exist for characterizing these differentiated cells.

Conclusions:

Human embryonic stem cells hold significant promise for cellular therapies targeting degenerative diseases, particularly in cardiovascular repair.
Further research and ethical considerations are crucial for the clinical application of hES cell-derived therapies.
The generation and characterization of hES cell derivatives are key steps towards realizing their therapeutic potential.